87.11
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CLX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$96.44
Offen:
$90.99
24-Stunden-Volumen:
13.25M
Relative Volume:
5.33
Marktkapitalisierung:
$10.53B
Einnahmen:
$6.76B
Nettoeinkommen (Verlust:
$770.00M
KGV:
14.23
EPS:
6.1203
Netto-Cashflow:
$778.00M
1W Leistung:
-11.72%
1M Leistung:
-16.43%
6M Leistung:
-22.54%
1J Leistung:
-37.12%
Clorox Co Stock (CLX) Company Profile
Firmenname
Clorox Co
Sektor
Telefon
(510) 271-7000
Adresse
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX vs PG, UL, CL, KVUE, KMB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CLX
Clorox Co
|
87.11 | 10.53B | 6.76B | 770.00M | 778.00M | 6.1203 |
|
PG
Procter Gamble Co
|
147.26 | 342.91B | 86.72B | 16.69B | 15.03B | 6.8375 |
|
UL
Unilever Plc Adr
|
59.76 | 130.51B | 56.67B | 6.96B | 7.39B | 3.1265 |
|
CL
Colgate Palmolive Co
|
87.26 | 70.01B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
KVUE
Kenvue Inc
|
17.43 | 33.46B | 15.12B | 1.47B | 1.72B | 0.764 |
|
KMB
Kimberly Clark Corp
|
97.67 | 32.42B | 16.56B | 1.75B | 1.84B | 6.36 |
Clorox Co Stock (CLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2026-02-11 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-10-01 | Bestätigt | Barclays | Underweight |
| 2025-01-07 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-11-06 | Hochstufung | TD Cowen | Sell → Hold |
| 2024-10-01 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-23 | Eingeleitet | TD Cowen | Sell |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-03-26 | Hochstufung | Jefferies | Underperform → Hold |
| 2024-03-01 | Fortgesetzt | Goldman | Sell |
| 2024-02-05 | Herabstufung | DA Davidson | Buy → Neutral |
| 2023-12-15 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-11-22 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-11-13 | Eingeleitet | Jefferies | Underperform |
| 2023-11-06 | Hochstufung | UBS | Sell → Neutral |
| 2023-11-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-10-12 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-10-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-10-02 | Hochstufung | DA Davidson | Neutral → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Hold |
| 2023-08-03 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2023-02-17 | Eingeleitet | Citigroup | Neutral |
| 2022-10-18 | Eingeleitet | Evercore ISI | Underperform |
| 2022-10-17 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | Fortgesetzt | BofA Securities | Underperform |
| 2022-07-13 | Eingeleitet | Raymond James | Outperform |
| 2022-02-04 | Herabstufung | Atlantic Equities | Neutral → Underweight |
| 2022-02-04 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-04 | Bestätigt | JP Morgan | Underweight |
| 2022-02-04 | Bestätigt | Morgan Stanley | Underweight |
| 2022-02-04 | Bestätigt | UBS | Sell |
| 2022-02-04 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | Bernstein | Mkt Perform → Underperform |
| 2022-01-26 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-11-02 | Bestätigt | DA Davidson | Neutral |
| 2021-11-02 | Bestätigt | Deutsche Bank | Hold |
| 2021-11-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-11-02 | Bestätigt | Wells Fargo | Underweight |
| 2021-09-03 | Herabstufung | Argus | Buy → Hold |
| 2021-08-04 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-08-04 | Bestätigt | Citigroup | Buy |
| 2021-08-04 | Bestätigt | Credit Suisse | Neutral |
| 2021-08-04 | Bestätigt | Deutsche Bank | Hold |
| 2021-08-04 | Bestätigt | Morgan Stanley | Underweight |
| 2021-08-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2021-08-04 | Bestätigt | UBS | Sell |
| 2021-08-04 | Bestätigt | Wells Fargo | Underweight |
| 2021-06-24 | Eingeleitet | UBS | Sell |
| 2021-05-03 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2021-03-18 | Herabstufung | DA Davidson | Buy → Neutral |
| 2021-02-19 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2021-01-20 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-10-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-30 | Eingeleitet | DA Davidson | Buy |
| 2020-03-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2020-03-16 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2020-03-09 | Hochstufung | Argus | Hold → Buy |
| 2019-10-03 | Bestätigt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-05-20 | Herabstufung | Argus | Buy → Hold |
| 2019-05-02 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-02 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2019-04-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-03-07 | Eingeleitet | Credit Suisse | Outperform |
| 2018-12-06 | Bestätigt | BofA/Merrill | Neutral |
| 2018-09-25 | Hochstufung | Argus | Hold → Buy |
| 2018-07-18 | Herabstufung | Goldman | Neutral → Sell |
| 2018-04-19 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-02-08 | Herabstufung | Argus | Buy → Hold |
| 2018-01-04 | Hochstufung | BofA/Merrill | Underperform → Neutral |
Alle ansehen
Clorox Co Aktie (CLX) Neueste Nachrichten
The Clorox Company Q3 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
Is Clorox Co (CLX) a Bargain After 9.7% Drop? GF Value Says Unde - GuruFocus
Clorox Co. stock underperforms Friday when compared to competitors - MSN
Clorox’s Purell Deal Expands Health Focus As Earnings Outlook Softens - simplywall.st
Clorox (NYSE:CLX) Given New $97.00 Price Target at Citigroup - MarketBeat
These Analysts Lower Their Forecasts On Clorox Following Q3 EarningsClorox (NYSE:CLX) - Benzinga
Clorox (NYSE:CLX) Price Target Lowered to $95.00 at JPMorgan Chase & Co. - MarketBeat
Clorox (CLX) Faces Challenges with Mixed Q3 Results and Downgraded Outlook - GuruFocus
Why Clorox (CLX) Shares Are Getting Obliterated Today - The Globe and Mail
TD Cowen cuts Clorox stock price target on guidance cut, ERP issues - Investing.com Canada
Clorox (NYSE:CLX) Shares Gap Down Following Analyst Downgrade - MarketBeat
Morgan Stanley Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price - MarketBeat
Clorox stock hits 52-week low at $91.00 amid challenging year - Investing.com
Vanguard Group Inc. Lowers Stock Position in The Clorox Company $CLX - MarketBeat
SanDisk, Western Digital, Clorox And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
UBS cuts Clorox stock price target on weaker guidance outlook - Investing.com
Morgan Stanley cuts Clorox stock price target on sales struggles By Investing.com - Investing.com India
Evercore ISI cuts Clorox stock price target on margin pressures By Investing.com - Investing.com Canada
Goldman Sachs cuts Clorox stock price target on guidance reduction - Investing.com
Clorox Co (CLX) Q3 2026 Earnings Call Highlights: Navigating Challenges with Strategic Innovations By GuruFocus - Investing.com Canada
Clorox Co (CLX) Q3 2026 Earnings Call Highlights: Navigating Cha - GuruFocus
CLX SWOT Analysis: Key Insights from Q2 2026 10-Q Filing - GuruFocus
Clorox Sees Margin Hit from Middle East Conflict, Consumer Pressure - CookOut News
Clorox (CLX) Q3 FY2026: EPS $1.54 vs $1.51 Est (Beat), Revenue $ - GuruFocus
Clorox (CLX) Revises Gross Margin Projections Amid Various Headw - GuruFocus
CLX Sees Decline in Gross Margin Amid Rising Costs - GuruFocus
Earnings call transcript: Clorox Q3 2026 beats EPS estimates amid mixed results - Investing.com Canada
Clorox (NYSE:CLX) Releases FY 2026 Earnings Guidance - MarketBeat
Clorox slides as FY2026 profit outlook is cut and margin expectations worsen - Quiver Quantitative
Clorox Co. stock outperforms competitors on strong trading day - MarketWatch
Clorox shares fall 6% as weak guidance overshadows Q3 earnings beat - Investing.com Canada
Consumer Products Giant Clorox Shares Are Hitting New 52-Week Lows Thursday: Here's Why - Benzinga
Clorox (NYSE:CLX) Posts Q1 CY2026 Sales In Line With Estimates But Stock Drops - Yahoo Finance
Q3 2026 Clorox Co Earnings Call Transcript - GuruFocus
Clorox (NYSE: CLX) posts Q3 2026 results and closes $2.25B GOJO deal - Stock Titan
CLOROX|DE ($CLX) Releases Q3 2026 Earnings - Quiver Quantitative
Clorox: Fiscal Q3 Earnings Snapshot - marketscreener.com
Chair and CEO Linda Rendle on Q3 FY26 performance and outlook - The Clorox Company
Clorox (NYSE: CLX) cuts 2026 EPS outlook as GOJO deal closes - Stock Titan
Clorox Reports Q3 Fiscal Year 2026 Results, Updates Outlook - Stock Titan
MSN Money - MSN
Clorox (CLX) Expected Earnings and Market Developments - GuruFocus
Clorox set to report earnings amid cost pressures, guidance concerns - Investing.com UK
Clorox set to report earnings amid cost pressures, guidance concerns By Investing.com - Investing.com Australia
Clorox Co. Stock (US1890541097): Declares Quarterly Dividend of 30 Cents Per Share - AD HOC NEWS
Clorox (CLX) Set to Report Q3 Earnings with Strong Expectations - GuruFocus
Vanguard Capital Management stakes 7.35% in Clorox (NYSE: CLX) - Stock Titan
Clorox Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Clorox Co. Stock Plummets to New 52-Week Low at $95.73 - Markets Mojo
Clorox (CLX) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
The Clorox Co. Stock Plummets to New 52-Week Low at $96.38 - Markets Mojo
Finanzdaten der Clorox Co-Aktie (CLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):